Winter 2019 CSAM Newsletter

• An Interview with CSAM’s New President Dr. Anthony Albanese – Pgs. 1-2; 7
• Low Barrier Buprenorphine for Opioid Use Disorder: A Feasible Strategy to Save Lives and Livelihoods – Pgs. 3; 11
• CSAM Addiction Medicine Review Course and Board Exam Preparation Track 2019 – Pgs. 4-5
• Timmen Cermak, MD Receives Vernelle Fox Award – Pg. 6
• CSAM’s Membership Now Tops 700! – Pg. 6
• CSAM Community Service Award Goes to David Lisonbee, CEO of Twin Town Treatment Centers – Pg. 7
• MERF Provides 54 Scholarships to 2019 Addiction Medicine Review Course in Anaheim – Pgs. 8-9
• Highlights of the CSAM Leadership Development Retreat at Asilomar – Pgs. 10-11
• CSAM Board of Directors Election Results Announced – Pg. 12
• CSAM Executive Director to Retire in 2020 – Pg. 13
• Newly Released: Guidelines for Physicians Working in California Opioid Treatment Programs – Pg. 13
• Welcome New CSAM Members! – Pg. 14
• CSAM Opposes Changes to Confidentiality of Substance Use Disorder Patient Records (42 CFR Part 2) – Pg. 15
• CSAM’s Addiction Medicine Review Course is Now Available Online! – Pg. 15
• State of the Art in Addiction Medicine Conference | August 26-29, 2020 – Pg. 16